In drug safety, pharmacovigilance, drug development and many other areas that we are involved in there are extensive discussions and even more extensive documents written to evaluate benefits and risks. Most of us don’t think too much about the concept of risk itself from a more theoretical and conceptual point of view. Let’s take a look at risk in this framework. There is a large literature on risk in the medical, financial, psychiatric and philosophical worlds. Here is an idiosyncratic review of risk.
You can view the full article and comment at the blog’s new location: http://www.telerx.com/blog/risk/